MindMap Gallery Hypothalamus-Pituitary Axis
Welcome to a mind map that will unravel the intricate workings of the Hypothalamus-Pituitary Axis, a fundamental system in our bodies that governs various physiological processes. The Hypothalamus and the Pituitary Gland, located in the brain, work in harmony to regulate hormone production and maintain homeostasis. In this mind map, we will explore the structure and functions of the Hypothalamus-Pituitary Axis. By mapping out the Hypothalamus-Pituitary Axis, we can gain a deeper understanding of how this complex system influences our overall well-being.
Edited at 2023-03-15 20:05:07Thyroid Gland
Thyroid Cancer
Causes
4 types
Papillary
most common (70–80%), 3x women
derived from thyroid follicular cells
spread lymphatic, multicfocal
Follicular
derived from thyroid follicular cells
10-15%, 2x women
agressive and spreads to lungs & bones
Anaplastic
Uncommon 10%, 1.5x men
Undifferentiated carcinoma
Very agressive & spreads via lymph nodes & blood
Medullary
Uncommon 5-10%, 1.5x men
Causes
Exposure to radiation, nuclear fall-out and neck irradiation
Presentation
lump (solitary or multinodular) in the neck, in a clinically euthyroid patient with no other symptoms.
Lumps generally benign
Can present symptoms due to bony metastasis
Tests
TSH & Free T4
Fine needle aspiration
Radionuclide scanning
Serum calcitonin and carcino-embryonic antigen (CEA)
Chest X-ray
U/S
CT or MRI
Treatment
Surgical
Thyroidectomy
Medical
Radioactive iodine (131I)
External beam radiotherapy
Hyperthyroidism
Causes
Excessive thyroid hormones
History
More in women in 3rd to 4th decade
Pathology
Fig 6.12
Presentation
Severity
Clinical
Overt
Manifestation
Table 6.13
Investigations
TSH and T4
T3 levels
Thyroid autoantibodies
U/S
Radioactive iodine uptake
Chest x-ray & CT
Treatment
Initial
b-Blockers
Identify and address the underlying cause
Medical
Antithyroid drugs
Propylthiouracil
Methimazole
Radioactive iodine
Surgical
Thyroidectomy
Hypothyroidism
Causes
Deficiency of thyroid hormone (Table 6.10)
Presentation
Severity
Clinical
Overt
Manifestation
Table 6.11
Myxoedema
Treatment
Thyroxine
IV liothyronine + hydrocortisone
Diseases
Hypothyroidism
Hyperthyroidism
Thyroid cancer
Tests
Total & Serum Free thyroxine
Hyperthyroidism
Hypothyroidism
Basal TSH
Hyperthyroidism
Hypothyroidism
Free T3
For toxicosis
Thyroid auto-antibodies
Physiology
2 thyroid glands connected by isthimus
Thyroid follicles with follicular cells
Thyroid hormones ( T3 & T4 )
Calcitonin ( Parafollicular cells)
Hypothalamus-Pituitary Axis
Hypothalamus
Location : Near the thalamus
Hormones secreted
Excitatory
Inhibitory
Pituitary
Size : 1-1.5 cm in diameter, pea shaped, in the hypophyseal fossa of the sella turcica of the sphenoid bone
Regions
Anterior lobe (Adenohypophysis) ; 75% , made of epithelial tissue
Regions
pars distalis is the larger portion
pars tuberalis forms a sheath around the infundibulum
Blood supply (Hypophyseal Portal System)
Internal carotid arteries → superior hypophyseal arteries → hypothalamus → primary plexus of the hypophyseal portal system → hypophyseal portal veins → infundibulum → anterior pituitary → secondary plexus.
Neutosecretory neuron cells → hypothalamic releasing and inhibiting hormones in cell bodies → hormones in vesicles → reach axon terminals → Exocytosis by nerve impulses → primary plexus of the hypophyseal portal system → act on anterior pituitary cells → secondary plexus capillaries → hormones secreted by anterior pituitary cells → anterior hypophyseal veins → general circulation → target tissues/endorcine flands (tropic hormones)
Cell types
Somatotrophs
human growth hormone → insulinlike growth factors
Thyrotrophs
thyroid-stimulating hormone → control thyroid gland
Gonadotrophs
gonadotropins: follicle-stimulating hormone → Act on gonads
luteinizing hormone → Act on gonads
Lactotrophs
prolactin → increases milk production in mammalary cells
Corticotrophs
adrenocorticotropic hormone → adrenal cortex → gluco-corticoids
melanocyte-stimulating hormone
Regulation of hormone secretion
Neurosecretory cells in hypothalamus
Releasing hormones
GHRH
TRH
GnRh
PRH
CRH
Inhibiting hormones
GHIH
PIH
Dopamine
Negative feedback loop
Thyrotrophs
Gonadotrophs
Corticotrophs
Posterior lobe (Neurohypophysis) composed of neural tissue
Regions
pars nervosa the larger bulbar portion
infundibulum attaches pituitary gland to the hypothalamus
pars intermedia atrophies during human fetal development and ceases to exist
Blood supply (Hypophyseal Portal System)
Internal carotid arteries → inferior hypophyseal arteries → posterior pituitary → capillary plexus of the infundibular process → posterior hypophyseal veins
Neuronal cell bodies of the neurosecretory cells (paraventricular and supraoptic nuclei of the hypothalamus) → hormone in vesicles → axons form the hypothalamohypophyseal tract → Axon terminals in posterior pituitary → Stored → Nerve impulse trigges exocytosis and hormone release → capillary plexus of the infundibular process → posterior hypophyseal veins → target cells
Hormones
Oxytocin
Impacts mothers utreus & breast
ADH
Impacts urine production
Pituitary
GH
Acromegaly
Pathology
Insidious disorder caused by pituitay adenoma secreting GH → bony & soft tissue overgrowth
Causes Acromegaly → caused by hypothalamic or ectopic GHRH
Scope of disease
Acromegaly can manifest singly/ combination of GH excess , local tumor effects or hypopituitarism
Multisystem disease. Increased GH leads to bone growth
GH excess leads to enlargement of heart, thyroid, liver or kidney
Hypertension 40%, IR 40%, MEN 5%
Clinical features
Diagnosis delayed by 9 years
Sweating, headache, tiredness, paraesthesia of hand, feet or arthralgia
Course features, macroglossia, prognathism, interdental separation, spade like hands, carpal tunnel syndrome, proximal muscle weakness
See Table 6.9
Investigations
Initial
(Growth hormone) glucose suppression test
Further
Anterior pituitary function tests
Goldmann perimetry
MRI of head
Management
Initial
Normalization of GH level, reversal of effect of pituitary tumor, treatment of hypopituitarism
Medical
Somatostatin analogues
Dopamine agonists
Radiotherapy
Surgical
Transsphenoidal surgery
Deficiency
Pathology
Children
Idiopathic growth hormone deficiency
Adult
Hypothalamic/Pituitary damage or growth hormone deficiency
Scope of disease
Children
Reduced growth rate
Reduced muscle mass
Bone remodelling
Adults
Asymptomatic
Poor sense of well-being, CV risk, muscle mass , bone density reduction
Clinical Features
Children
Failure to thrive
Adults
Fatigue, lack of energy, reduced muscle mass, insulin resistance GH def. suspected if clinical eval. uncovers hypothalamic/pituitary damage
Investigations
Pharma stimulation test
Insulin Tolerance Test
MRI of head
Management
Initial
No need for GH, treat other def. first
Medical
GH replacement
In children before epiphyses fused
In adults improves QOL without impact on survival
ADH Secretion Syndrome
Cause
Syndrome of inappropriate ADH secretion (SIADH) is the most common cause of hyponatraemia.
Pathology
See Fig
Peripheral oedema absent since extra & intracellular spaces impacted
Brain can be impacted but adapts well
Clinical features
Can be asymtomatic
Severe hyponatremia can cause CNS complications & oedema
Abnormalities in renal, liver, adrenal and thyroid fuction has to be excl.
Investigations
Paired serum and urine osmolality
Serum osmolalities
serum hypo-osmolality (<270 mOsm/kg).
Urine osmolalities
inappropriately concentrated urine (>100 mOsm/kg)
Urinary sodium excretion > 20 mmol/L
Management
Identify and address underlying cause
Fluid restriction
Demeclocycline
Diabetes insipidus
Cause
Large vol. of dilute/insipid urine passed due to
failure of vasopressin release (central)
failure of the kidneys (nephrogenic) to respond to vasopressin
Pathology
Table 6.6
Clinical Feature
persistent polyuria, nocturia, thirst and polydipsia
onset of central diabetes insipidus is usually more abrupt than nephrogenic diabetes insipidus
Dehydration can lead to loss of consciousness & coma
Nocturia is uncommon with primary polydipsia
Investigation
Initial
24-hour urine collection
Urea and electrolytes
Futher
Water deprivation test
CT/MRI of the brain
Management
Initial
Increase fluid intake
Identify and address any underlying cause
Medical management
Desmopressin
Pituitary Adenomas
Epidemiology
5-20% Autopsies
Less common with female prepoderance b/w 30-50 yrs
Causes
Types
Mostly benign
< 0.5% are carcinomas
Defined by size
Microadenomas ( < 10 mm)
Macroadenomas ( >10 mm)
Classified as per prominent cell type
Lactotrophs (PRL) -50%
Somatotrophs (GH) - 30%
Corticotrophs (ACTH) 20%
Gonadotrophs (LH, FSH)
Thyrotrophs (TSH)
Non-functioning adenomas (NFA) - contain secretory granules (25%)
Scope of Disease
Mass effects
Visual disturbances
Headaches
Cranial nerve palsies
Increased appetite, thrist, coma due to invasion into hypothalamus
Apoplexy
Hypopituitarism
Acute compression of optic chasm
Endocrine manifestations
Hypopituitarism
Prolactin excess
Acromegaly due to GH hypersecretion
Cushing disease due to ACTH excess
Macro-orchidism due to FSH excess
Thyrotoxicosis due to TSH excess
Tests
Basal anterior pituitary hormone profile
Dynamic function test
Perimetry
MRI
Treatment
Medical
Hormone replacement
Hormone antagonism
Surgical
Transsphenoidal surgery
Radiotherapy
Hyperprolactinaemia
Causes
Most common disorder of anterior pituitary
Pathology
Fig 6.5
Presentation
Manifestation
Reduced fertility impacts men and women
Spontaneous or expressible galactorrhoea
80% women
20% men
Oligo/amenorrhoea & symptoms of oestrogen def. in women of childbearing age
Men less frequently seek treatment for libido loss, gynaecomastia stc.
Symptoms of hypo-pituitarism
Pituitary adenoms give rise to headaches & visual disturbance
Investigations
Prolactin level
Thyroid function test
Pregnancy test
Basal anterior pituitary hormone profile
MRI of head
Treatment
Initial
Identify and address the underlying cause
Medical
Aim
Restoration of gonadal function
Reversal of galactorrhoea
In macroprolactinomas
Tumor size reduction
Avoidance of mass effects
Dopamine antagonists
Surgical
Transsphenoidal surgery
Radiation therapy
Hypopituitarism
Causes
Deficiency of one or more pituitary hormone (Table 6.3)
Develop in sequence GH - HT - TSH - ACTH - Prolactin - PPH
Presentation
Manifestation
Endocrine axes affected (Table 6.4)
Severity
Clinical
Overt
Rate of onset of hormone deficiency
Investigation
Aim
Confirm presence of hormone deficiency
Exclude disease of target organ
Test pituitary hormone levels on max stimulation
Tests done
Screening profile
Cortisol
TSH
Free T4
LH, FSH, Oestradiol (women)
Testosterone (men)
Prolactin , IGF
Combined pituitary stimulation test
Treatment
Hormone replacement
Hydrocortisone for glucocorticoid replacement
L-thyroxine replacement therapy
Sex steroid replacement therapy
GH replacement therapy
Diseases
Hypopituitarism
Hyperprolactinaemia and prolactinoma
Pituitary adenomas
Diabetes Insipidus
ADH secretion syndrome
GH Deficiency
Acromegaly
Tests
Basal anterior pituitary hormone profile
Assessment of
TSH + Thyroxine
ACTH + Cortisol
FSH/LH + Oestrogen/Testosterone
PRL
IGF-1
Dynamic pituitary function tests
Stimulation test for suspected hormone deficiency
Supression test in hormone excess
ITT
Glucagon test
Arginine test
Physiology
See Hypothalamus-Pituitary Axis